Papyrus Therapeutics

Management Team

Paul Blake, FRCP

Founder & CEO

  • 30+ years management and drug development experience
  • Numerous NDA/sNDA/MAA approvals, including three entirely novel indications
  • Former Chief Development Officer at Oxford Biomedica
  • Former Executive VP of Worldwide Medical and Regulatory Operations at Cephalon
  • Former Chief Medical Officer and Senior VP of Clinical R&D at SmithKline Beecham

Hani Gabra, PhD FRCP

Founder & CSO

  • Internationally-recognized translational medical oncologist and gynecologic cancer expert with 30+ years of academic experience
  • Professor Emeritus in Medical Oncology at Imperial College London
  • Visiting Professor at the Center for Cancer Biomarkers at University of Bergen
  • Former VP in early clinical development at Astra Zeneca
  • Former CMO and head of clinical development at BerGenBio AS

Adam Marsh, PhD

VP Biomarker Development

  • Professor computational biology – University of Delaware
  • CSO at Genome Profiling LLC